ClinicalTrials.Veeva

Menu

Multi-provincial Cohort for Hypertension (MUCH)

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status

Unknown

Conditions

Hypertension

Treatments

Other: Cardiovascular risk factors
Drug: Antihypertensive Agents

Study type

Observational

Funder types

Other

Identifiers

NCT03150888
2016YFC0900902

Details and patient eligibility

About

The purpose of this study is to construct hypertension specialized cohort using uniform standards and specifications. This study timely collected multi-dimensional clinical information through electronic medical records, mobile health, data integration, informatics and computer modern techniques, linking self-reported data and big data platforms from different sources to timely obtain the incidence and mortality data, and integrating hypertension cohort samples and the associated clinical records systematically, in order to build a 30-thousand hypertension specialized cohort with fine phenotypic data and blood/urine samples, thus far to provide support for the development of precise medicine research and related industries.

Enrollment

30,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of hypertension
  • over 18 years old
  • ti sign the informed consent

Exclusion criteria

  • with life-threatening severe disease, such as severe tumor or AIDs
  • pregnancy or lactating women,or plan to pregnant within half a year,
  • with severe mental disorders
  • participating in clinical trials

Trial design

30,000 participants in 2 patient groups

Hospital based hypertension cohort
Treatment:
Drug: Antihypertensive Agents
Other: Cardiovascular risk factors
Community based hypertension cohort
Treatment:
Drug: Antihypertensive Agents
Other: Cardiovascular risk factors

Trial contacts and locations

6

Loading...

Central trial contact

Yue Qi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems